Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective.
Chiappini S, Guirguis A, Schifano N, Corkery JM, Semeraro F, Mosca A, D'Andrea G, Duccio Papanti G, Arillotta D, Floresta G, Martinotti G, Schifano F. Chiappini S, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Dec 6;136:111213. doi: 10.1016/j.pnpbp.2024.111213. Online ahead of print. Prog Neuropsychopharmacol Biol Psychiatry. 2024. PMID: 39647692 Free article.
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis.
Guirguis A, Chiappini S, Papanti P GD, Vickers-Smith R, Harris D, Corkery JM, Arillotta D, Floresta G, Martinotti G, Schifano F. Guirguis A, et al. Among authors: chiappini s. Eur Neuropsychopharmacol. 2024 May;82:82-91. doi: 10.1016/j.euroneuro.2024.02.003. Epub 2024 Mar 19. Eur Neuropsychopharmacol. 2024. PMID: 38508100 Free article.
The Benzydamine Experience: A Systematic Review of Benzydamine Abuse.
Chiappini S, Miuli A, Mosca A, Pettorruso M, Guirguis A, John MC, Martinotti G, Di Giannantonio M, Schifano F. Chiappini S, et al. Curr Neuropharmacol. 2021 Oct 18;19(10):1728-1737. doi: 10.2174/1570159X19666210113151136. Curr Neuropharmacol. 2021. PMID: 33441070 Free PMC article.
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.
d'Andrea G, Pettorruso M, Di Lorenzo G, Rhee TG, Chiappini S, Carullo R, Barlati S, Zanardi R, Rosso G, Di Nicola M, Andriola I, Marcatili M, Clerici M, Dell'Osso BM, Sensi SL, Mansur RB, Rosenblat JD, Martinotti G, McIntyre RS. d'Andrea G, et al. Among authors: chiappini s. J Affect Disord. 2024 Mar 1;348:314-322. doi: 10.1016/j.jad.2023.12.038. Epub 2023 Dec 23. J Affect Disord. 2024. PMID: 38145840
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances.
Chiappini S, Vaccaro G, Mosca A, Miuli A, Stigliano G, Stefanelli G, Giovannetti G, Carullo R, d'Andrea G, Di Carlo F, Cavallotto C, Pettorruso M, Di Petta G, Corkery JM, Guirguis A, Stair JL, Martinotti G, Fazel S, Schifano F. Chiappini S, et al. Neurosci Biobehav Rev. 2024 Jul;162:105691. doi: 10.1016/j.neubiorev.2024.105691. Epub 2024 May 10. Neurosci Biobehav Rev. 2024. PMID: 38733894 Free article. Review.
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).
Pettorruso M, Guidotti R, d'Andrea G, De Risio L, D'Andrea A, Chiappini S, Carullo R, Barlati S, Zanardi R, Rosso G, De Filippis S, Di Nicola M, Andriola I, Marcatili M, Nicolò G, Martiadis V, Bassetti R, Nucifora D, De Fazio P, Rosenblat JD, Clerici M, Maria Dell'Osso B, Vita A, Marzetti L, Sensi SL, Di Lorenzo G, McIntyre RS, Martinotti G; REAL-ESK Study Group. Pettorruso M, et al. Among authors: chiappini s. Psychiatry Res. 2023 Sep;327:115378. doi: 10.1016/j.psychres.2023.115378. Epub 2023 Jul 28. Psychiatry Res. 2023. PMID: 37574600 Free article.
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group.
d'Andrea G, Chiappini S, McIntyre RS, Stefanelli G, Carullo R, Andriola I, Zanardi R, Martiadis V, Sensi SL, Sani G, Clerici M, Di Lorenzo G, Vita A, Pettorruso M, Martinotti G. d'Andrea G, et al. Among authors: chiappini s. Am J Geriatr Psychiatry. 2023 Dec;31(12):1032-1041. doi: 10.1016/j.jagp.2023.06.016. Epub 2023 Jul 8. Am J Geriatr Psychiatry. 2023. PMID: 37479669 Free article.
77 results